Ceribell (CBLL) Depreciation and Depletion (2023 - 2026)
Ceribell (CBLL) posted Depreciation and Depletion of $60000.0 for Q1 2026, up 150.0% on a QoQ basis from $24000.0 in Q4 2025, and down 33.33% year-over-year from $90000.0 in Q1 2025.
Ceribell (CBLL) Depreciation and Depletion (2023 - 2026) Analysis & Trends
Ceribell's Depreciation and Depletion history runs 4 years deep, the most recent figure standing at $60000.0 for Q1 2026.
- Quarterly Depreciation and Depletion fell 33.33% year-over-year to $60000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $270000.0 (down 29.69% YoY) and the FY2025 annual result came in at $300000.0, down 25.0% from the prior year.
- Depreciation and Depletion was $60000.0 for Q1 2026 at Ceribell, up from $24000.0 in the prior quarter.
- Across five years, Depreciation and Depletion topped out at $110000.0 in Q2 2024 and bottomed at $24000.0 in Q4 2025.
- A 4-year average of $82636.4 and a median of $90000.0 in 2023 frame the typical range for Depreciation and Depletion.
- Annual changes were most pronounced in 2024 — Depreciation and Depletion jumped 77.97% — and 2025, when it tumbled 77.14%.
- Ceribell's Depreciation and Depletion stood at $59000.0 in 2023, then soared by 77.97% to $105000.0 in 2024, then tumbled by 77.14% to $24000.0 in 2025, then surged by 150.0% to $60000.0 in 2026.
- Business Quant data shows CBLL's Depreciation and Depletion at $60000.0 in Q1 2026, $24000.0 in Q4 2025, and $97000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 381.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 120.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 308.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 89.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 78.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Ceribell | 613.16 Mn | 471.97 Mn | 23.12 Mn | 60,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 60,000.00 |
| Mar 31, 2026 | 60,000.00 |
| Dec 31, 2025 | 24,000.00 |
| Dec 31, 2025 | 24,000.00 |
| Sep 30, 2025 | 97,000.00 |
| Sep 30, 2025 | 97,000.00 |
| Jun 30, 2025 | 89,000.00 |
| Jun 30, 2025 | 89,000.00 |
| Mar 31, 2025 | 90,000.00 |
| Mar 31, 2025 | 90,000.00 |
| Dec 31, 2024 | 105,000.00 |
| Dec 31, 2024 | 105,000.00 |
| Sep 30, 2024 | 79,000.00 |
| Sep 30, 2024 | 79,000.00 |
| Jun 30, 2024 | 110,000.00 |
| Jun 30, 2024 | 110,000.00 |
| Mar 31, 2024 | 106,000.00 |
| Mar 31, 2024 | 106,000.00 |
| Dec 31, 2023 | 59,000.00 |
| Dec 31, 2023 | 59,000.00 |